Nab-paclitaxel,Cyclophosphamide
immunitybio
[]
immunitybio announces presentation at asco gi 2023 of fully enrolled trial in third-line and greater pancreatic canc.. $ibrx 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice